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Objective: We assessed the measurement equivalence and feasibility of the paper-and-pencil and touch-screen
modes of administration of the Taiwan Chinese version of the EORTC QLQ-PR25, a commonly used questionnaire
to evaluate the health-related quality of life (HRQOL) in patients with prostate cancer in Taiwan.
Methods: A cross-over design study was conducted in 99 prostate cancer patients at an urology outpatient clinic.
Descriptive exact and global agreement percentages, intraclass correlation, and equivalence test based on minimal
clinically important difference (MCID) approach were used to examine the equity of HRQOL scores between these
two modes of administration. We also evaluated the feasibility of computerized assessment based on patients’
acceptability and preference. Additionally, we used Rasch rating scale model to assess differential item functioning
(DIF) between the two modes of administration.
Results: The percentages of global agreement in all domains were greater than 85% in the EORTC QLQ-PR25. All
results from equivalence tests were significant, except for Sexual functioning, indicating good equivalence. Only one
item exhibited DIF between the two modes. Although nearly 80% of the study patients had no prior computer-use
experience, the overall proportion of acceptance and preference for the touch-screen mode were quite high and
there was no significant difference across age groups or between computer-use experience groups.
Conclusions: The study results showed that the data obtained from the modes of administration were equivalent.
The touch-screen mode of administration can be a feasible and suitable alternative to the paper-and-pencil mode for
assessment of patient-reported outcomes in patients with prostate cancer.
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The proper use of patient-reported outcome (PRO)
measurement in clinical settings has become increasingly
important to obtain more comprehensive information to
guide clinical decision-making, treatment planning,
and clinical management [1]. Traditionally, PRO data
are collected through face-to-face interviews or patient
self-report to paper-based questionnaires, which is labor* Correspondence: wmliang@mail.cmu.edu.tw
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reproduction in any medium, provided the orintensive and time consuming. With the emergence
of computer technology, electronic methods of data
collection (e.g., touch-screen response or interactive
voice response) are becoming more popular and viable
alternatives to conventional surveys carried out in clinical
practice [1-3].
Electronically administered questionnaires allow data to
be automatically entered real time into a database, after
which the score is immediately calculated; thus, data
coding errors and the workload of health professionals are
reduced [3,4]. The time required by the patient to complete
the electronically administered questionnaire such as
electronic patient-reported outcome (ePRO) questionnaire,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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addition, increased use of the ePRO questionnaires in
clinical assessments may promote integration of PRO and
clinical information. Once patients have completed the
ePRO questionnaires during their clinic visits, their item
responses will be automatically scored and summarized
for potential clinical use with other patient-related
information. The integrated results are readily available
in easily interpretable reports that can be viewed together
by the clinician and their patient during clinical encounter.
Therefore, the process can enhance the efficiency and
quality of healthcare and patient-physician communications
[3,6,7]. Nonetheless, the equivalence of the ePRO version
and its original paper-and-pencil version should be
thoroughly evaluated, and the patient preference and accept-
ance should also be examined before shifting from
paper-and-pencil data to ePROs without demonstrating its
feasibility [6,8]. Some studies have examined and validated
the measurement equivalence of paper-and-pencil-based ver-
sion and touch-screen computer-based version; the results
showed that the data collected from paper- and computer-
administered PROs were very similar and the touch-screen
version was well accepted by most subjects [6-10].
Prostate cancer is a common disease among men in
many Western countries and developed Asian countries.
The standardized incidence in Taiwan (adjusted by the
2000 world population) has increased from 1.86 per
100,000 men in 1979 to 28.77 per 100,000 men in 2010
[11]. Moreover, long-term survival results have shown that
health-related quality of life (HRQOL) has become an im-
portant outcome measure in different clinical settings [12].
The European Organization for Research and Treatment of
Cancer (EORTC) Quality of Life Study Group developed
the EORTC QLQ-PR25, a 25-item questionnaire designed
for use among patients with localized and metastatic pros-
tate cancer, is a commonly used tool to assess HRQOL in
patients with prostate cancer. It includes four domains that
assess urinary symptoms, bowel symptoms, treatment-
related symptoms, and sexual activity and functioning. The
results of international field validation have been published
in 2008 [13]. The paper-and-pencil versions of the EORTC
QLQ-PR25 have satisfactory reliability and validity [12-14].
In this study, we used the Taiwan Chinese version of the
EORTC QLQ-PR25 questionnaire published by Chie et al.
in 2010 [12]. It was also shown to be reliable and valid to
assess HRQOL using the modern test theory approach in
our previous study [15]. To the best of our knowledge, the
psychometric properties and feasibility of the touch-screen
version of this questionnaire for prostate cancer patients
have not been well established, and no data have been re-
ported in Taiwan. Therefore, in this study we sought to as-
sess the measurement equivalence and feasibility of the
paper-and-pencil and touch-screen versions of the EORTC
QLQ-PR25 in patients with prostate cancer in Taiwan.Methods
Research design and data collection
A randomized cross-over design was used in this study.
A total of 107 prostate cancer patients in various stages
of illness and treatment were enrolled from September
2008 to October 2009 in the Department of Urology
outpatient clinic of China Medical University Hospital in
Central Taiwan. Patients who could not read, speak, or
write Chinese were excluded. All patients provided
written informed consent. The study procedures were
approved by the Institutional Review Board of the China
Medical University Hospital.
Initially, 107 patients with prostate cancer were enrolled
and randomly assigned into one of the two study groups,
with 54 patients in the paper-and-pencil-version-first
group (denoted as paper/touch-screen group) and 53
patients in the touch-screen-version-first group (denoted
as touch-screen/paper group). Each patient was asked to
complete both versions of the questionnaires. Patients
in the paper/touch-screen group were given the
paper-and-pencil version of the questionnaire first,
followed by the touch-screen version after a 120-minute
interval. By contrast, the touch-screen/paper patients were
given the touch-screen questionnaire first, followed by the
paper-and-pencil version 120 minutes later. Once the
patients finished the first mode of administration, they
were led to the education room to watch health education
videos. This was to dilute the memory of their responses
to the questions from the first administration as the same
set of question were asked at the second administration.
After completing each questionnaire for the two modes
of administration, each patient was asked to answer a
usability and feasibility questionnaire to indicate their
preference and acceptance of the touch-screen version
of the questionnaire. Ninety-nine patients successfully
completed both assessments and eight patients had to
leave early and did not complete the whole procedure.
The study scheme is shown in Figure 1.
HRQOL measures
The prostate-specific module EORTC QLQ-PR25 is a self-
administered questionnaire that includes 4 subscales
for assessment of Urinary symptoms (9 items, labeled
US31–US39), Bowel symptoms (4 items, BS40–BS43), Hor-
monal treatment-related symptoms (6 items, TS44–TS49),
and Sexual activity and function (6 items, SX50–SX55). In
this study, no patients reported using incontinence aid,
therefore, the item (US38, “Has wearing an incontinence
aid been a problem for you? Answer this question only if
you wear an incontinence aid.”) was excluded from the
Urinary symptom domain for analysis. Each of the 24
retained items was scored from 1 to 4 (1 = “Not at all”,
2 = “A little”, 3 = “Quite a bit”, and 4 = “Very much”) [13].
Domain scores of the EORTC QLQ-PR25 were linearly
A total of 107 patients with prostate 
cancer were enrolled and randomly 
assigned into one of the two groups.
54 patients completed 
paper-and-pencil versions first.
(EORTC QLQ-PR25)
53 patients completed 
touch-screen versions first.
(EORTC QLQ-PR25)
Washout period: 120 minutes interval
5 patients withdrew.




50 patients completed the
paper-and-pencil versions.
(EORTC QLQ-PR25)
49 patients completed the feasibility 
and preference of touch-screen 
version questionnaire.
50 patients completed the feasibility 
and preference of touch-screen 
version questionnaire.
Figure 1 Study structure in the study.
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manual, which requires answering at least half of the
total number of items in the domain. Higher scores
reflected either more symptoms (e.g., Urinary, Bowel, and
Hormonal treatment-related symptoms) or higher levels
of functioning (e.g., Sexual activity and function) [16].
Setting of the touch-screen version
The touch-screen version was developed by a team of
physicians specializing in prostate cancer, technicians
with expertise in system design and programming,
epidemiologists, and statisticians. Java software was used
to develop the system using an Oracle database [17].
Statistical analysis
Descriptive statistics for continuous variables are presented
as means and standard deviations, whereas categorical
variables are presented as frequencies and proportions. We
assessed the differences in demographic characteristics and
time to complete the questionnaire between the two study
groups using independent t-test for continuous data and
Chi-square or Fisher’s exact test for categorical data. And a
paired t-test was used to compare the administration time
between two modes.
We used a mixed model to assess the quality of the
cross-over design, wherein the dependent variable wasthe domain score and the main independent variables
were administration order (order effect), mode type
(mode effect), and their interaction (carry-over effect). A
random effect accounted for the covariance structure
induced by the repeated measures. Gender and age
effects were also included for adjustment of confounding
effect. After testing the mode-by-order interaction, we fit
the model again without interaction term (i.e., main-effect
model) if the carry-over effect is not statistically significant
at 5% level. No significant carry-over effect in the
interaction model and no significant order effect in the
main-effect model indicated methodologically appropriate
for the cross-over design.
The agreement of scores between the paper and the
computerized administrations was assessed at the individ-
ual patient level. “Exact agreement” referred to as patients
who provided the same responses to individual questions
on both paper-and-pencil- and touch-screen-administered
questionnaires. “Global agreement” was defined as the
proportion of agreement within one adjacent response
category in either higher or lower direction [18]. We
also used intraclass correlations (ICC) calculated from
a random-effects mixed model and interpreted the results
based on criteria proposed by Bartko et al. [19] and
Stokdijk et al. [20] as follows: an ICC < 0.40 indicated
poor agreement, 0.40 to 0.59 indicated moderate
Table 1 Demographic characteristics and time for completion of questionnaires of the two groups of prostate cancer
patients
Paper/Touch-screen Touch-screen/Paper
(n = 49) (n = 50) p-value
Age (year) (N (%))
<= 65 12 (24.5) 13 (26.0) 0.778b
66-70 11 (22.5) 14 (28.0)
71-75 12 (24.5) 13 (26.0)
> 75 14 (28.5) 10 (20.0)
Mean (SD) 70.1 (7.6) 69.0 (8.1) 0.463a
Education level (N (%)) 0.701b
College or above 14 (29.8) 13 (26.0)
Senior high 11 (23.3) 15 (30.0)
Junior high 11 (21.4) 7 (14.0)
Primary school or less 12 (25.5) 15 (30.0)
Previous experience using computers (N (%))
Yes 10 (20.4) 9 (18.0) 0.837b
No 39 (79.6) 41 (82.0)
Time for completion of questionnaires (min)d
Paper version (Mean (Range)) 17.9 (5.0 ~ 39.0) 14.7 (6.0 ~ 31.0) 0.022a
Touch-screen version (Mean (Range)) 15.7 (5.0 ~ 30.0) 20.5 (9.0 ~ 41.0) 0.002a
p-value 0.516c <0.001c
ap-value was evaluated by Independent t-test.
bp-value was evaluated by Chi-square test.
cp-value was evaluated by Paired t-test.
dTime for completion of the two questionnaire modes by four questionnaires, including the EORTC QLQ-C30, EORTC QLQ-PR25, IIEF-5
(International Index of Erectile Function), and IPSS (International Prostate Symptom Score).
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and > 0.75 indicated excellent agreement. Highly positive
ICCs indicate that paper and computer measures covary,
and the mean and variability of the scores are similar [2].
In addition, we used a “Two One-Sided Test” procedure
to determine whether the two administrations produce
equivalent results. Equivalence testing is operationally
different from the conventional method (e.g., independent
t-test), which is mainly used to detect difference rather
than equivalence. Equivalence testing refers to a trial
wherein the primary objective is to show that the response
to the novel intervention is as good as the response to the
standard intervention. This procedure begins with
attempting to demonstrate that they are equivalent within
a practical, preset limit δ (i.e., |μpaper − μtouch − screen| < δ),
and sets a null hypothesis that the two mean values are
not equivalent (i.e., |μpaper − μtouch − screen| ≥ δ). The method
we used is computationally identical to perform two
one-sided t-tests with the following sets of hypotheses:Left tail Right t
H0 : D ¼ μpaper−μtouch−screen ≤‐δ
H1: D ¼ μpaper−μtouch−screen > ‐δ
H0 : D ¼ μpaper−μ
H1 : D ¼ μpaper−μ
This premise is conceptually opposite to that of the
conventional independent t-test procedure [21]. The
occurrence of both rejections from two one-sided t-tests
at 5% significant level indicates that the two modes are
equivalent, which means that the difference between
the groups is not more than a tolerably small amount
(i.e., |μpaper − μtouch − screen| < δ) [22,23]. This small amount
of allowable difference is the margin that defines the “zone
of indifference” where the interventions are considered
equivalent [24]. In our analysis, we used a minimum
clinically important difference (MCID) of 5 (i.e., δ = 5)
based on previous studies [25,26], as the tolerable
amount to assess equivalence.
The required sample size for this study was based on
the assumption that no clinical differences are present
between the domain scores of the two administration
modes under a cross-over design study. The MCID for
each domain score of the EORTC QLQ-PR25 was set at
a five-point score, and the standard error of the domainail
touch−screen ≥δ
touch−screen <δ
Table 2 Exact and global agreements and ICC between






Urinary symptoms (8 items)c 629/791 (80%) 778/791 (98%) 0.78
Bowel symptoms (4 items) 351/396 (89%) 396/396 (100%) 0.72
Treatment-related symptoms
(6 items)
500/591 (85%) 574/591 (97%) 0.47
Sexual activity (2 items) 142/196 (72%) 187/196 (95%) 0.61
Sexual functioning (4 items)d 92/151 (61%) 133/151 (88%) 0.45
Number of total pairs = number of subjects × number of items – number of
missing pairs.
aExact agreement (in%): number of same response pairs/number of total pairs.
bGlobal agreement (in%): number of within one-difference response
pairs/number of total pairs.
cIn our study, there is no patients reported using incontinence aid, therefore,
we deleted an item (US38 “Incontinence aid”) from the Urinary symptom
domain, resulting in 8 items remained in this domain.
dSexual functioning items only apply to sexually active subjects. A total of
48 patients reported being sexually active. Meanwhile, forty-one missing pairs
occurred in this domain.
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minimum sample size was estimated to be 80 using
the statistical software PASS to detect an equivalence
difference of 5 with 80% power and 5% type I error.
Confirmation from modern measurement theory
Rasch analysis, based on the modern measurement theory,
has been shown to be a useful tool for the development of
new PRO measures and in evaluating the measurement
structure of existing PRO measures [27,28]. We used the
rating scale model (RSM) to estimate difficulty calibration
for each item. RSM, an extension of the dichotomous
Rasch model, for polytomous items with ordered response
categories was chosen as it is suitable for the items used in
this study. In Rasch analysis, differential item functioning
(DIF) can be used to examine item measurement invariance
[29,30]. In this study, DIF, an item lacking equivalence in
performance across the two groups or settings (e.g., paper-
and-pencil vs. touch-screen administration), was identified
statistically by conducting an independent t-test on the
difficulty calibration of each item. An item was said to
exhibit DIF if the test was significant (p < 0.05) [31].
Results
Demographic characteristics
Table 1 shows the demographic characteristics of the
study patients with prostate cancer. The mean age was
70.1 years in the paper-and-pencil/touch-screen group
and 69 years in the touch-screen/paper-and-pencil
group. The age range of patients was 57 years to 87 years.
More than half of the participants graduated from high
school. Approximately 80% of the patients had no
experience using a computer. No statistically significant
differences were observed for demographic characteristics
between the two groups.
Mixed model analysis
We conducted the mixed model with two main effects
(accounted for the mode effect and the order effect) and
their interaction (accounted for the carry-over effect).
No carry-over effects were found (p-value > 0.05). We
then removed the interaction and reran the model. No
order effect was observed (p-value > 0.05). The results
confirmed the quality of the cross-over design.
Exact and global agreement analysis
Table 2 shows the percentages of exact and global agree-
ments for each domain. In the “urinary symptoms” domain
that included 8 items, 791 paired responses (8 items × 99
subjects – 1 missing pair) were noted. Out of 791, 629
paired responses were identical, which yielded an exact
agreement percentage of 80% (= 629/791). Our results
showed that the percentages of exact agreement for all
domains in EORTC QLQ-PR25 ranged from 61% to 89%.The percentages of global agreement (i.e., the difference of
scores of each paired responses was within one response
category) ranged from 88% to 100%.
Intraclass correlation coefficient analysis
The intraclass correlation coefficients (ICCs) ranged
from 0.45 (“Sexual Function” domain) to 0.78 (“Urinary
symptoms” domain) for all the domains in the EORTC
QLQ-PR25 (Table 2), indicating moderate to excellent
agreement for each domain between two modes.
Equivalence test based on minimal important difference
approach
Table 3 shows the results of the domain scores and
equivalence test based on the MCID approach for
comparison of touch-screen and paper-and-pencil
modes. Equivalence tests based on the MCID of 5
were used to assess the equivalent properties between the
two modes and the results showed the measurement
scales between two modes were equivalent for all domains
except for Sexual functioning domain.
DIF analysis
Table 4 shows the results of DIF of Rasch analysis. No
DIF was found for EORTC QLQ-PR25 for prostate
cancer patients, except item 31 (“Urinary frequency
during daytime”). In general, the measurement properties
for each item were equivalent between the two modes.
Acceptance and preference for touch-screen mode
Table 5 shows the patients’ views about the use of touch-
screen questionnaire administration. Approximately 92%
of patients reported that the touch-screen questionnaire
administration was easy to use and approximately 97%
Table 3 Mean scores and equivalence test between touch-screen and paper-and-pencil modes
Paper-and-pencil Touch-screen Equivalence testc
EORTC QLQ-PR25a Mean SD Mean SD 95% CI of Left taile Right taile
Mean differenced p-value p-value
Urinary symptoms (8 items) 19.5 13.5 21.1 13.3 −3.3 to 0.1 <0.001 <0.001
Bowel symptoms (4 items) 5.3 8.6 5.7 7.9 −1.5 to 1.0 <0.001 <0.001
Treatment-related symptoms (6 items) 11.1 10.2 10.3 9.2 −1.1 to 2.9 <0.001 <0.001
Sexual activity (2 items) 19.4 20.2 20.2 20.8 −5.0 to 2.3 0.048 <0.001
Sexual functioning (4 items)b 62.3 22.0 61.8 20.9 −5.7 to 9.5 0.076 0.415
aAll scores were linearly converted to a 0 to 100 scale, with higher scores indicating a higher level of functioning and more severe symptoms.
bSexual functioning items are conditional and only applicable to those being sexually active. A total of 48 patients reported being sexually active in this study.
cBased on the equivalence test using the score 5 as the tolerably difference.
dMean difference = paper-and-pencil mean score - touch-screen mean score.
eLeft tail significance indicates μpaper – μtouch-screen > −5. Right tail significance indicated μpaper – μtouch-screen < 5. Therefore, both tails significance indicates
| μpaper – μtouch-screen | < 5.
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92% of patients stated that they liked using the
touch-screen to complete the questionnaire. More than
two-thirds (67%) of the patients said they preferred using
the touch-screen mode to fill out the questionnaire, while
30% preferred using the paper-and-pencil mode. Based on
the results stratified by age, higher percentages of accept-
ance and preference were observed in patients < = 70 years
of age compared with patients aged > 70 years. However,
no statistically significant difference for each question
was observed when the two age groups were compared.
One hundred percent of prostate cancer patients with
experience using a computer and 90% to 96% of patients
without previous computer experience believed that
the touch-screen mode was user friendly. Although
nearly 80% of the prostate cancer patients had no
computer experience, the overall percentages of accept-
ance and preference for the touch-screen mode was quite
high and was non-significantly different compared
with the results between the patients with and without
computer experience.
Discussion
The measurement equivalence between paper-based ver-
sions and touch-screen versions of the questionnaires has
been previously demonstrated in various diseases [4,7,18,32],
but to the best of our knowledge no data on the EORTC
QLQ-PR25 in Taiwan have been reported. Our results
showed the percentages of global agreement in all EORTC
QLQ-PR25 domains were > 85%. All results from equiva-
lence tests were significant, indicating measurement equiva-
lence, except for Sexual functioning domain. The results of
measurement equivalence were confirmed using the mod-
ern test theory approach. Only one out of 24 items exhibited
DIF between the two modes. The overall rate of acceptance
and preference for the touch-screen mode were quite high.
In order to develop a computerized version of the
EORTC QLQ-PR25 for use in this study, we completeda required user’s agreement that permits us to use the
questionnaire or for any change such as computerizing
the questionnaire, and be held responsible for the quality
of the measurement [33]. Permission was granted, per
its policy, to allow us to use and migrate the paper form of
the EORTC QLQ-PR25 to a tablet format for research pur-
pose. Moreover, the U.S. Food and Drug Administration
(FDA) released a PRO guidance in 2009, which suggested
that a small randomized study is needed to provide
evidence to confirm the new instrument’s adequacy for any
change of instrument such as changing an instrument from
paper to electronic format [34].
In our randomized cross-over designs, subjects were
randomized into one of the two following sequences: paper
then touch-screen or touch-screen then paper. Therefore,
each subject served as his own control. Cross-over trials
were conducted within participant comparisons, whereas
parallel designs were conducted between participant com-
parisons. The influence of confounding covariates and the
majority of between-patient variation could be eliminated
using a cross-over design [34,35]. In this study, our results
from mixed model analysis showed that no mode-by-order
interaction effect was present; thus, the carry-over effect
did not exist. Moreover, when we refitted the main effect by
interaction term removal, the order effect did not exist.
These results showed that the cross-over randomized
design in our study is methodologically appropriate. Fewer
patients may be required in the cross-over design to attain
the same level of statistical power and precision. Moreover,
this design permitted opportunities of head-to-head trials,
and subjects receiving multiple treatments can express
preferences for or against particular treatments [35,36].
In this study, we used intraclass correlation coefficients
(ICCs), i.e., Pearson correlation coefficients when there
were only two evaluations within a subject, to estimate
the between-mode (touch-screen to paper; paper to
touch-screen) test-retest reliability (0.40-0.84 for each
item, 0.45-0.78 for each domain, and 0.80 for total score),
Table 4 Using Rasch analysis with rating scale model in differential item functioning analysis
EORTC QLQ-PR25 Paper Computer Differential item functioning
Items ranked by difficulty Difficulty SE Difficulty SE Difficulty SE p-value
Urinary symptoms (US)a
US37 Painful voiding (least frequent) −3.055 0.369 −2.790 0.321 −0.266 0.489 0.588
US39 Limitation of daily activities because of US −1.035 0.250 −1.306 0.251 0.271 0.354 0.445
US36 Urinary incontinence −0.199 0.225 −0.349 0.226 0.150 0.319 0.638
US35 Need to remain close to toilet −0.149 0.223 −0.346 0.226 0.197 0.318 0.536
US31 Urinary frequency in daytime 0.599 0.210 1.261 0.200 −0.662 0.290 0.024
US34 Sleep deprivation because of US 1.118 0.206 0.766 0.207 0.352 0.292 0.229
US33 Urinary urgency 1.118 0.206 1.420 0.198 −0.302 0.286 0.292
US32 Nocturia (most frequent) 1.537 0.204 1.301 0.199 0.236 0.285 0.410
Bowel symptoms (BS)a
BS42 Fecal blood (least frequent) −0.656 0.413 −0.839 0.404 0.183 0.578 0.752
BS41 Fecal incontinence −0.656 0.413 −0.535 0.377 −0.120 0.559 0.830
BS40 Limitation of daily activities because of BS 0.437 0.339 0.313 0.328 0.124 0.472 0.793
BS43 Bloated feeling (most frequent) 0.879 0.327 1.026 0.315 −0.147 0.454 0.747
Treatment-related symptoms (TS)a
TS45 Breast tenderness (least frequent) −1.676 0.384 −1.489 0.381 −0.187 0.541 0.731
TS46 Swelling in legs or ankles −0.449 0.257 −0.151 0.247 −0.298 0.357 0.406
TS44 Hot flushes −0.384 0.253 −0.812 0.301 0.429 0.393 0.277
TS47 Bother due to weight loss −0.035 0.234 0.284 0.221 −0.320 0.322 0.322
TS48 Bother due to weight gain 0.668 0.200 0.515 0.209 0.153 0.289 0.598
TS49 Felt less masculine (most frequent) 1.756 0.165 1.677 0.167 0.078 0.235 0.739
Sexual activity (SX)b
SX50 Sexual interest (more likely) −0.977 0.334 −1.338 0.315 0.362 0.459 0.432
SX51 Sexual activity (less likely) 0.968 0.344 1.359 0.330 −0.391 0.477 0.414
Sexual functioning (SX)b,c
SX55 Sexual comfort (more likely) −1.945 0.303 −1.408 0.270 −0.537 0.406 0.189
SX54 No ejaculation problems −0.607 0.228 −0.257 0.220 −0.350 0.316 0.272
SX53 No erectile problems −0.047 0.210 −0.047 0.214 0.000 0.299 1.000
SX52 Sexual enjoyment (less likely) 2.441 0.220 1.888 0.192 0.552 0.292 0.061
aRaw responses: 1: Very much; 2: Quite a bit; 3: A little; 4: Not at all, higher score means less frequent symptom.
bRaw responses: 4: Very much; 3: Quite a bit; 2: A little; 1: Not at all, higher score means more activity/functioning.
cSexual functioning items are conditional and only applicable to those being sexually active. A total of 48 patients reported being sexually active in this study.
Difficulty: Item difficulty, higher difficulty means worse HRQOL/more frequent symptom.
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(paper-paper) test-retest reliability (0.61-0.93 for each
item and 0.85 for total score) of the EORTC QLQ-PR25
questionnaire in another study [37]. The between-mode
test-retest results may reflect the limitations of the original
instrument rather than those of the data collection mode.
The equivalence testing that was used in reliability
analysis was performed by two one-sided t-tests, which
tested paired differences to be equal [38]. All the results
from equivalence tests were significant indicating good
equivalence, excluding Sexual functioning domain. It should
be noted that of the six Sexual activity and functioningitems in the EORTC QLQ-PR25, four items (SX52–SX55)
are conditional and apply only to sexually active
respondents. In this study, approximately half of the
patients reported not being sexually active and did
not respond to those 4 items, resulting in fewer responses
to those conditional items in this domain. Moreover, quite
a few responses were missing or showed variance in
this domain due to the participants’ embarrassment
or reluctance to share details about their private sexual life
in this study population [39,40]. The above reasons may
have resulted in less precise measurement in the Sexual
functioning domain.
Table 5 Feasibility and preference assessments for the touch-screen mode
Age group Computer experience
All <= 70 > 70 p-value Yes No p-value
(n = 99) (n = 50) (n = 49) (n = 19) (n = 80)
Feeling touch-screen mode was easy to use. 91.9% 96.0% 87.0% 0.159a 100.0% 90.0% 0.347a
Feeling user-interface of touch-screen mode was user-friendly. 97.0% 100.0% 93.9% 0.117a 100.0% 96.3% 0.999a
Expressing they liked touch-screen mode. 91.9% 96.0% 87.8% 0.159a 100.0% 90.0% 0.347a
Which version did you like?
Neither 2.0% 0.0% 4.1% 0.117b 5.3% 1.3% 0.639b
Paper and pencil mode 30.3% 24.0% 36.7% 31.6% 30.0%
Touch-screen mode 66.7% 74.0% 59.2% 63.2% 67.5%
Both 1.0% 2.0% 0.0% 0.0% 1.3%
ap-value was evaluated by Fisher’s exact test.
bp-value was evaluated by Chi-square test to compare two groups: touch-screen mode and the others (three versions combined).
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difference in the difficulty papameters between two modes
of administration (paper-and-pencil vs. touch-screen).
Application of DIF analysis in this study allowed a
thorough evaluation of measurement equivalence. We
first estimated the difficulty calibration of each item
for each mode separately using the rating scale model
to avoid correlation problem. Then, DIF analysis was
applied to assess the equivalence of item difficulties
between these two modes. Although the problem of
correlated data potentially existed, as the same patients in
these two groups responded to the same survey twice
due to the cross-over design, we mainly performed a
comparison of the difficulty calibration measures,
which is not so sensitive to the correlated effects of
the cross-over design. For example, when performing the
parallel comparison between two groups, the correlated
data problem was mitigated to some extent due to the
different sequence of administration, i.e., half the patients
completed the questionnaire using the touch-screen
mode first, followed by the paper mode, and the
other half completed the paper mode first, followed
by the touch-screen mode. In addition, the influence
of confounding covariates and much of the between-
patient variation could be eliminated using a cross-
over design, which could also increase the efficiency for
estimating and testing [35,41]. DIF also benefits from this
type of design.
Furthermore, there are two possible reasons to explain
the inconsistency between DIF analysis and equivalence/
agreement analysis. First, these two approaches are
conceptually different. DIF was used to test the scale
measurement properties for each individual item between
the two modes, while equivalence analysis was used to
show the mean score difference of patients between two
modes. Second, equivalence test as applied in this study
began with a null hypothesis that the two mean valueswere not equivalent, and attempted to demonstrate that
they were equivalent within a practical, preset limit.
This test is conceptually opposite to the independent
t-test in the DIF analysis and would lead to the result
that the Sexual functioning items were more limited
in equivalence/agreement, but the DIF test failed to
identify this.
In this study, touch-screen administration required
approximately 30% more time to complete than the paper
questionnaire (20.5 min vs. 14.7 min). We speculate that
the difference in time to complete the questionnaire
may be because the touch-screen/paper group was
given the touch-screen version questionnaire first, and
most respondents (82%) had no experience using a
computer. Furthermore, the patients may have spent
more time because this was their first exposure to the
EORTC QLQ-PR25 questionnaire; thus, the amount of
time taken for the touch-screen mode was longer than
that for the paper mode in the touch-screen/paper group
(20.5 min vs 14.7 min) (p < 0.001). However, we found that
when the touch-screen mode was performed in the
second assessment, the time it took to complete the
questionnaire decreased significantly (p = 0.002) (Table 1).
We anticipate that the time to complete the questionnaire
via touchscreen will decrease over time as patients get
used to the system. In addition, the results can be analyzed
in real-time to facilitate clinical diagnosis and improve
patient-physician relationships. A previous study reported
that the transfer of assessment data to a computer may
differentially influence the responses of older patients
[42]. Previous studies of patients aged from 48.1 years to
65.0 years showed the touch-screen mode was a reliable
and user-friendly method of assessing quality of life [43-46].
Our results showed that 97% of the patients reported
that the touch-screen version was user-friendly and
approximately 67% reported preferring the touch-screen
version to the paper-and-pencil version despite the
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using a computer in our study population. Moreover,
most patients (92%) reported that the touch-screen was
easy to use, which was similar to the results reported by
Pouwer et al. [43], which showed that the touch-screen
questionnaire was easier for patients to complete even if
they had rarely or never used a computer.
Patients often expect the physician to know the results
of a questionnaire shortly after they have completed
it; however, PROs assessed using the paper-and-pencil
mode cannot be transferred to the physician’s clinic
in real-time. Various studies have confirmed that
incorporating routine standardized HRQOL assessments
in clinical oncology practice can facilitate the commu-
nication and discussion of HRQOL issues and can
increase physicians’ awareness of their patients’ qual-
ity of life. Computer measurements are well accepted
by patients who generally consider ePROs to be useful
tools with which to inform their doctor about their
problems [47-49].
A limitation of this study was that the washout period
between the two modes of administration was only
120 minutes, which might not have been sufficiently
long to completely eliminate the carry-over effects. It is
possible that some residual memory or carry-over effects
from the first administration were still present when the
patients were asked the same set of questions during the
second administration. As a result, the level of agreement
between the two administrations is possibly inflated [35,41].
A longer interval, however, may require patients to spend
too much time waiting, which might therefore discourage
them from completing the second administration.
Asking patients to come back on another day would
likely greatly reduce the subjects’ willingness to participate.
Most importantly, because of the longer waiting time, the
patients’ condition may change and result in different
answers, thereby affecting the consistency of the responses.
Therefore, after careful consideration, we chose an interval
of 120 minutes. Moreover, once patients had finished the
first questionnaire, they were taken to the education room
to watch health education videos which helped to “dilute”
the memory of the first administration. Thus, we believe
that the memory effect was likely lessened due to the
120-minute interval between tests and the use of health
education videos.Conclusions
Our results showed that the touch-screen mode of the
Taiwan Chinese version of the EORTC QLQ-PR25 had
demonstrated good reliability and was well accepted by
most prostate cancer patients in Taiwan, suggesting its
potential use as an alternative to the paper-and-pencil
mode for measurement of PROs.Abbreviations
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